NICE recommends Boehringer Ingelheim's Pradaxa to treat fatal blood clots in adults

The UK's National Institute for Health and Care Excellence (NICE) has recommended the anti-blood clotting drug dabigatran, Boehringer Ingelheim's Pradaxa, to treat fatal blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism) in…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news